Smithers Pharmaceutical Development Services to Present Molecular Bioanalysis Insights at the AAPS 2026 Summer Scientific Forum
AAPS 2026 Summer Scientific Forum will bring together pharmaceutical and bioanalytical leaders to discuss emerging strategies shaping drug development and analytical science. During the event at the Hilton Columbus Downtown in Columbus, Ohio, Smithers Pharmaceutical Development Services will engage with sponsors, scientists, and executive decision-makers focused on advancing complex bioanalytical programs.
Christina Satterwhite, President, Connie Scott, Senior Director, Business Development, Deepali Gururani, Scientific Project Manager, and Agostinho G. Rocha, Site Director of Smithers Pharmaceutical Development Services, will represent Smithers Pharmaceutical Development Services throughout the conference at Booth 15. Direct access to executive leadership enables efficient, decision-oriented conversations aligned with sponsor priorities.
Molecular Bioanalysis Continues to Shape Early Development Programs
Molecular bioanalysis remains a critical component of preclinical and early-stage drug development programs. As cell and gene therapies, nucleic acid therapeutics, and complex biologics continue to advance, sponsors face increasing pressure to develop assays capable of balancing high sensitivity with long-term robustness and reproducibility.
At the AAPS 2026 Summer Scientific Forum, Smithers Pharmaceutical Development Services will contribute to these discussions through a scientific presentation focused on molecular bioanalysis strategy and assay performance considerations.
Presentation Focus: Balancing Sensitivity and Robustness in Molecular Bioanalysis
Agostinho G. Rocha, PhD, will present an abstract titled “Balancing Sensitivity and Robustness in Molecular Bioanalysis.” The presentation will examine practical strategies for improving assay sensitivity while maintaining fit-for-purpose performance across molecular bioanalytical workflows.
The session will explore how extraction approaches, assay design, qPCR, and digital PCR methodologies contribute to overall assay sensitivity and robustness. Additional discussion areas will include validation strategy development and approaches for establishing reliable workflows capable of supporting regulatory and development decision-making.
The presentation is designed to address challenges commonly encountered during preclinical development, where sponsors require analytical methods capable of generating reproducible, decision-ready data under accelerated timelines.
Experience-Driven Scientific Discussion
Smithers Pharmaceutical Development Services approaches molecular bioanalysis from an operational and scientific perspective grounded in real-world program execution. The company continues to expand its molecular bioanalysis capabilities through practical experience supporting sponsor programs across a range of therapeutic modalities and development stages.
Rather than focusing on theoretical discussion, the presentation will highlight applied scientific considerations informed by active bioanalytical development programs and validated workflows. Sponsors attending the conference will gain insight into strategies that support assay development, validation, and long-term analytical reliability.
A Strategic Forum for Bioanalytical Decision-Makers
The AAPS Summer Scientific Forum provides a focused environment for scientific and strategic discussions surrounding bioanalysis, drug development, and analytical innovation. The meeting attracts pharmaceutical executives, bioanalytical scientists, and development leaders evaluating external partnerships and analytical capabilities during early-stage development.
For organizations advancing preclinical programs, discussions surrounding assay sensitivity, validation strategy, and molecular bioanalysis readiness remain directly tied to development timelines and regulatory progression. Smithers Pharmaceutical Development Services will be available throughout the conference to discuss these considerations with sponsors seeking experienced bioanalytical support.
Meet Smithers Pharmaceutical Development Services at Booth 15
Sponsors attending the AAPS 2026 Summer Scientific Forum are encouraged to connect with Smithers Pharmaceutical Development Services during the conference to discuss molecular bioanalysis strategy, assay development, and preclinical analytical support requirements.
Meetings with the Smithers Pharmaceutical Development Services team can be scheduled in advance to ensure dedicated time with executive and scientific leadership during the event.
